The Food and Drug Administration wants new curbs on yet another popular prescription sleep medication because of concerns that adults may still be driving drowsy the next day.
The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness.